Mr. Damien McCallion:

I will take the second question first. It would be a matter for MedLab as to why it went to Manchester. It may help to give the general context. There has been serious shortage of screeners, of medical scientists, who can do cytopathology. That has been a serious challenge in this country and others as people move to HPV. As I mentioned earlier, people regard it as a very narrow career path. When people go from doing 100% of something to only doing 15% of something, clearly that has an impact on the resource that is there in many of the NHS facilities. I am giving that as context. It would be a matter for MedLab as to why it went to Manchester rather than staying in Dublin.

Dr. Henry will speak about laboratories' contact with GPs and consultants.